Skip to content
healthcare.dev

FASLODEX

NDC 0310-0720, Fulvestrant, injection, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-0720
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
INJECTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021344
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0720 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FULVESTRANT50 mg/mL

Pharmacologic classes

Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
0310-0720-10003100720102 SYRINGE, GLASS in 1 CARTON (0310-0720-10) / 5 mL in 1 SYRINGE, GLASS

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/83d7a440-e904-4e36-afb5-cb02b1c919f7
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0310-0720

Use it

Look up 0310-0720 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0720 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-0720. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.